Cochrane Abstracts
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"A Therapeutic‐only Versus Prophylactic Platelet Transfusion Strategy for Preventing Bleeding in Patients With Haematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic‐only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation.
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic‐only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation. Accessed March 21, 2025.
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic‐only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation
A Therapeutic‐only Versus Prophylactic Platelet Transfusion Strategy for Preventing Bleeding in Patients With Haematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic‐only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
ID - 439382
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439382/all/A_therapeutic‐only_versus_prophylactic_platelet_transfusion_strategy_for_preventing_bleeding_in_patients_with_haematological_disorders_after_myelosuppressive_chemotherapy_or_stem_cell_transplantation
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
